Bio3E Tech Industries

Belkins
Biotech for life in space. -----------PROJECT CONCEPT----------- Bio3E CLOSED SYSTEM We are making closed system for growing plants that don't rely on matter exchange with any part outside the system. Bio3E closed systems can use anywhere included vacuum. Bio3E LIVE TECH Bio3E means synergy of 3 factors necessary for support life: Ecology, Economy and Energy. Bio3E AI CONTROL Using artificial intelligence for control and adjust the processes taking place inside Bio3E closed systems. In this case, it's a combination of a computer program and drones intended for system maintenance.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

CIPLA AND STEMPEUTICS JOIN FORCES FOR THE LAUNCH OF STEMPEUCEL® IN INDIA

Cipla | August 24, 2020

news image

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its partner Stempeutics Research Pvt. Ltd has received regulatory approval by the Drug Controller General of India (DCGI) for the launch of Stempeucel® in India. The product is indicated for the treatment of CLI due to Buerger's Disease and Atherosclerotic Peripheral Arterial Disease. It is the first allogeneic cell therapy product to be approved for commercial use in India and the first ste...

Read More

SEVERITY OF COVID-19 MAY DEPEND ON YOUR INDIVIDUAL GENETIC VARIATION IN IMMUNE SYSTEM

SciTechDaily | April 19, 2020

news image

Genetic variability in the human immune system may affect susceptibility to, and severity of infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease (COVID-19). The research is published on April 17, 2020, in the Journal of Virology, a publication of the American Society for Microbiology. Individual genetic variation may explain differences in the strength of immune responses. Certain immune system genes, called human leukocyte...

Read More

MEDICAL

FRESH FROM RAISING $200M, BRITISH BIOTECH WITH AN HQ IN RALEIGH MULLS TARGETING COVID-19

Verona Pharma | November 19, 2020

news image

A British clinical-stage biotech firm with U.S. base camp in Raleigh is investigating the alternative of repurposing its leading drug candidate to treat COVID-19 patients. Flush with $200 million after a July raise, the London-based Verona Pharma is now making large walks with its "first-in-class" drug, ensifentrine, targeting chronic obstructive pulmonary disease (COPD). Now, against the backdrop of a pandemic, it’s pushing ahead with a pilot clinic...

Read More

US DRUG TEST CENTERS NOW OFFERING NATIONWIDE COVID-19 ANTIBODY TESTING

US Drug Test | July 21, 2020

news image

US Drug Test Centers, one of the largest testing companies in the United States, announced they are now offering COVID-19 Antibody Testing with FDA Emergency Use Authorization at 1,800+ locations nationwide. No prescription is necessary. To book an appointment, visit www.usdrugtestcenters.com, select a location, order a test and an order from a local doctor will be sent to you in 6-12 hours. The test includes a simple blood draw, and results are received usually within 24-48 hours.Antibody...

Read More

Cipla | August 24, 2020

news image

CIPLA AND STEMPEUTICS JOIN FORCES FOR THE LAUNCH OF STEMPEUCEL® IN INDIA

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its partner Stempeutics Research Pvt. Ltd has received regulatory approval by the Drug Controller General of India (DCGI) for the launch of Stempeucel® in India. The product is indicated for the treatment of CLI due to Buerger's Disease and Atherosclerotic Peripheral Arterial Disease. It is the first allogeneic cell therapy product to be approved for commercial use in India and the first ste...

Read More

SciTechDaily | April 19, 2020

news image

SEVERITY OF COVID-19 MAY DEPEND ON YOUR INDIVIDUAL GENETIC VARIATION IN IMMUNE SYSTEM

Genetic variability in the human immune system may affect susceptibility to, and severity of infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease (COVID-19). The research is published on April 17, 2020, in the Journal of Virology, a publication of the American Society for Microbiology. Individual genetic variation may explain differences in the strength of immune responses. Certain immune system genes, called human leukocyte...

Read More

MEDICAL

Verona Pharma | November 19, 2020

news image

FRESH FROM RAISING $200M, BRITISH BIOTECH WITH AN HQ IN RALEIGH MULLS TARGETING COVID-19

A British clinical-stage biotech firm with U.S. base camp in Raleigh is investigating the alternative of repurposing its leading drug candidate to treat COVID-19 patients. Flush with $200 million after a July raise, the London-based Verona Pharma is now making large walks with its "first-in-class" drug, ensifentrine, targeting chronic obstructive pulmonary disease (COPD). Now, against the backdrop of a pandemic, it’s pushing ahead with a pilot clinic...

Read More

US Drug Test | July 21, 2020

news image

US DRUG TEST CENTERS NOW OFFERING NATIONWIDE COVID-19 ANTIBODY TESTING

US Drug Test Centers, one of the largest testing companies in the United States, announced they are now offering COVID-19 Antibody Testing with FDA Emergency Use Authorization at 1,800+ locations nationwide. No prescription is necessary. To book an appointment, visit www.usdrugtestcenters.com, select a location, order a test and an order from a local doctor will be sent to you in 6-12 hours. The test includes a simple blood draw, and results are received usually within 24-48 hours.Antibody...

Read More